Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Abdominal Imaging|April 6, 2012
Spigelian hernia: CT findings and clinical relevanceMathieu Martin, Brice Paquette, Nicolas Badet, et al.Abdominal Radiology (New York)|July 14, 2016
Does IV contrast extravasation on CT in anticoagulant-related rectus sheath and iliopsoas hematoma predict hematoma expansion and patient outcomes?Marie Landecy, Brice Paquette, Lucie Revel, et al.Clinical Imaging|August 16, 2014
Retro-ureteral internal hernia after transperitoneal ureter reimplantation: an unusual cause of small bowel obstructionArnaud Flores, Amel Azizi, Ouaji Idelcadi, et al.Abdominal Imaging|May 10, 2014
Preoperative diagnosis of gangrenous acute cholecystitis: usefulness of CEUSLucie Revel, Jean Lubrano, Nicolas Badet, et al.Bulletin Du Cancer|October 2, 2019
[Radiologic response assessment in metastatic colorectal cancers]Achille Fabre, Nicolas Badet, Paul Calame, et al.Experimental Dermatology|March 8, 2017
Increased levels of circulating platelet-derived microparticles are associated with metastatic cutaneous melanomaJoséphine Moreau, Fabien Pelletier, Sabeha Biichle, et al.Liver International : Official Journal of the International Association for the Study of the Liver|June 23, 2018
Circulating levels of 3-hydroxymyristate, a direct quantification of endotoxaemia in noninfected cirrhotic patientsDelphine Weil, Jean-Paul Pais de Barros, Guillaume Mourey, et al.The Lancet. Oncology|July 26, 2018
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 studyStefano Kim, Eric François, Thierry André, et al.The Lancet. Oncology|March 28, 2024
Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 studyStefano Kim, Francois Ghiringhelli, Christelle de la Fouchardière, et al.Pageof 1